Galmed Pharmaceuticals Files 2024 Annual Report
Ticker: GLMD · Form: 20-F · Filed: Apr 2, 2025 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 20-F |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 20-F, pharmaceuticals
TL;DR
Galmed Pharma dropped its 2024 20-F, check financials for year-end Dec 31, 2024.
AI Summary
Galmed Pharmaceuticals Ltd. filed its annual 20-F report for the fiscal year ending December 31, 2024. The company, incorporated in L3 and headquartered in Ramat Gan, Israel, operates in the pharmaceutical preparations sector. This filing provides a comprehensive overview of its financial performance and business operations for the past year.
Why It Matters
This filing is crucial for investors and stakeholders to understand Galmed's financial health, operational performance, and strategic direction for the year ended December 31, 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Galmed is subject to inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 20-F filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-04-02 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Filer of the 20-F report
- 0001595353 (company) — Central Index Key for Galmed Pharmaceuticals Ltd.
- Ramat Gan (location) — City of business and mailing address
- 2024-12-31 (date) — Fiscal year end date
- 2025-04-02 (date) — Filing date of the 20-F report
FAQ
What is the primary business of Galmed Pharmaceuticals Ltd. as indicated in the filing?
The filing indicates that Galmed Pharmaceuticals Ltd. operates in the 'PHARMACEUTICAL PREPARATIONS' sector, with SIC code 2834.
What is the fiscal year end for Galmed Pharmaceuticals Ltd. for this report?
The Conformed Period of Report is 20241231, meaning the fiscal year ends on December 31, 2024.
When was this 20-F filing submitted to the SEC?
The filing was made on April 2, 2025, as indicated by the 'FILED AS OF DATE' and 'DATE AS OF CHANGE'.
Where is Galmed Pharmaceuticals Ltd. located?
The company's business and mailing address is located at 16 Abba Hillel Silver Rd., Ramat Gan, Israel.
What is the Central Index Key (CIK) for Galmed Pharmaceuticals Ltd.?
The Central Index Key for Galmed Pharmaceuticals Ltd. is 0001595353.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 2, 2025 regarding Galmed Pharmaceuticals Ltd. (GLMD).